Full references of Zero Nicotine project

[1] NIH Public Access: Treating Tobacco Dependence in a Medical Setting - CA Cancer J Clin. 2009 ; 59 (5): 314–326. doi:10.3322/caac.20031.
[2] Review: Tobacco harm reduction: the need for new products that can compete with cigarettes. Fagerström KO, Bridgman K. Addict Behav. 2014 Mar;39(3):507-11. doi: 10.1016/j.addbeh.2013.11.002. Epub 2013 Nov 10.
[3] Tob Control. 2014 Mar;23(2):133-9. doi: 10.1136/tobaccocontrol-2012-050859. Epub 2013 Mar 6. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes.
[4] Indian J Cancer. 2010 Jul;47 Suppl 1:3-8. doi: 10.4103/0019-509X.64373.Tobacco and health in India. Rao V1, Chaturvedi P. Subst Use Misuse. 2014 May;49(6):735-42. doi: 10.3109/10826084.2013.863937. Epub 2013 Dec 13. The economics of tobacco in Lebanon: an estimation of the social costs of tobacco consumption.
[5] ASH (Action on Smoking, Health) (2007). Nicotine replacement therapy guidelines for health care professionals on using nicotine replacement therapy for smokers not yet ready to stop smoking.(17 pp.). ASH (2012). E-cigarette use in Great Britain: 2010 and 2012. (5 pp.).
ASH (2013).Use of e-cigarettes in Great Britain among adults and young people.(4 pp.)
[6] Lewis, S., Arnott, D., Godfrey, C., & Britton, J. (2005). Public health measures to reduce smoking prevalence in the UK: How many lives could be saved? Tobacco Control, 14, 251–254.
[7]Lancet. 2013 Nov 16;382(9905):1629-37. doi: 10.1016/S0140-6736(13)61842-5. Epub 2013 Sep 9. Electronic cigarettes for smoking cessation: a randomised controlled trial.
[6]PLoS One. 2013 Jun 24;8(6):e66317. doi: 10.1371/journal.pone.0066317. Print 2013. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study.
[8] BMC Med. 2015 Mar 18;13:54. doi: 10.1186/s12916-015-0298-3. Electronic cigarette use and harm reversal: emerging evidence in the lung.
[9] Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J et al.. Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res. 2014; 20:218-25
[10]Tob Control. 2014 Mar;23(2):133-9. doi: 10.1136/tobaccocontrol-2012-050859. Epub 2013 Mar 6. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes.
[11] Nature. 2013 Sep 26;501(7468):473. doi: 10.1038/501473a. Regulation stacks up for e-cigarettes. Cressey D.
[12] Sci Rep. 2014 Feb 26;4:4133. doi: 10.1038/srep04133. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Farsalinos KE1
[13] Functional Upregulation of α4* Nicotinic Acetylcholine Receptors in VTA GABAergic Neurons Increases Sensitivity to Nicotine Reward.
[14] JAMA Psychiatry. 2014 Jul 1;71(7):797-805. doi: 10.1001/jamapsychiatry.2014.138.Brain nicotinic acetylcholine receptor availability and response to smoking cessation treatment: a randomized trial.
[15]Doc. AIPO_SIMeR
[16] Curr Top Behav Neurosci. 2015;24:99-123. doi: 10.1007/978-3-319-13482-6_4. Nicotine withdrawal. McLaughlin I1, Dani JA, De Biasi M.
[17] Tob Control. 2010 Apr;19(2):98-103. doi: 10.1136/tc.2009.031567. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Bullen C1, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M. [18]http://agivapenews.com/2015/07/11/dati-iss-utilizzatori-ecig-2014/
[19] direttiva UE_2014_40_it
[20] Psychopharmacology (Berl). 2016 Aug;233(15-16):2933-41. doi: 10.1007/s00213-016-4338-2. Epub 2016 May 27. Self-titration by experienced e-cigarette users: blood nicotine delivery and subjective effects. Dawkins LE, Kimber CF, Doig M, Feyerabend C, Corcoran O.
[21] Addiction. 2015 Aug;110(8):1352-6. doi: 10.1111/add.12942. Epub 2015 May 20. E-cigarettes generate high levels of aldehydes only in 'dry puff' conditions. Farsalinos KE, Voudris V, Poulas K.
[22] Proc (Bayl Univ Med Cent). 2016 Jul;29(3):280-3. Electronic cigarettes in the media. Payne JD, Orellana-Barrios M, Medrano-Juarez R, Buscemi D, Nugent K
[23] BMC Public Health. 2016 Sep 20;16:999. doi: 10.1186/s12889-016-3653-1. E-cigarette puffing patterns associated with high and low nicotine e-liquid strength: effects on toxicant and carcinogen exposure. Cox S, Kośmider L, McRobbie H, Goniewicz M, Kimber C, Doig M, Dawkins L.
[24] Subst Abuse Rehabil. 2016 Aug 18;7:111-8. doi: 10.2147/SAR.S94264. eCollection 2016. E-cigarettes for the management of nicotine addiction. Knight-West O, Bullen C.
[25] Regul Toxicol Pharmacol. 2016 Mar;75:58-65. doi: 10.1016/j.yrtph.2015.12.019. Epub 2015 Dec 29. Effect of variable power levels on the yield of total aerosol mass and formation of aldehydes in e-cigarette aerosols. Gillman IG, Kistler KA, Stewart EW, Paolantonio AR.
[26 ]NIH Public Access N Engl J Med. 2010 June 17; 362(24): 2295–2303. doi:10.1056/NEJMra0809890 Neal L. Benowitz, M.D.
[27] Int. J. Environ. Res. Public Health 2015, 12, 9046-9053; doi:10.3390/ijerph120809046 Tobacco-Specific Nitrosamines in Electronic Cigarettes: Comparison between Liquid and Aerosol Levels Konstantinos E. Farsalinos, Gene Gillman, Konstantinos Poulas and Vassilis Voudris
[28] PLoS One. 2015 Feb 6;10(2):e0116732. doi: 10.1371/journal.pone.0116732. eCollection 2015. Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. Lerner CA, Sundar IK, Yao H, Gerloff J, Ossip DJ, McIntosh S, Robinson R, Rahman I.
[29] Nicotine Tob Res. 2016 Sep;18(9):1845-52. doi: 10.1093/ntr/ntw081. Epub 2016 Mar 31. CHRNA4 and ANKK1 Polymorphisms Influence Smoking-Induced Nicotinic Acetylcholine Receptor Upregulation. Esterlis I, Hillmer AT, Bois F, Pittman B, McGovern E, O'Malley SS, Picciotto MR, Yang BZ, Gelernter J, Cosgrove KP.
[30] AAPS PharmSci. 2000 Mar; 2(1): 29–41. doi: 10.1208/ps020104 PMCID: PMC2750999 Pharmacogenomics: The promise of personalized medicine Laviero Mancinelli,corresponding Maureen Cronin, and Wolfgang Sadéecorresponding
[31] Clin Pharmacol Ther. 2006 Dec;80(6):703-14. Nicotine intake and dose response when smoking reduced-nicotine content cigarettes. Benowitz NL, Jacob P, Herrera B.
Others related Links:
http://www.who.int/tobacco/health_priority/en/
http://www.who.int/tobacco/research/cancer/en/
http://www.who.int/topics/tobacco/en/
http://www.globalissues.org/article/533/tobacco
http://stm.sciencemag.org/content/8/333/333ra49#login-pane